CIK 0001549595
- Large accelerated filer
Nurix Therapeutics, Inc.
Sign in to watch- Ticker
- NRIX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Nov 30
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 270838048
- Phone
- +1 415-660-5320
- Business address
- 1600 SIERRA POINT PKWY, BRISBANE, CA, 94005
- Former names
- Nurix, Inc.
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale EVP and COO sold 342 shares at $9.88 ($3,378)
- 4 Open-market sale Chief Financial Officer sold 721 shares at $9.88 ($7,121)
- 4 Open-market sale General Counsel sold 682 shares at $9.88 ($6,736)
- 4 Open-market sale Chief Scientific Officer sold 1,136 shares at $9.88 ($11,219)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale EVP and COO sold 424 shares at $11.78 ($4,995)
- 4 Open-market sale Chief Financial Officer sold 924 shares at $11.78 ($10,884)
- 4 Open-market sale General Counsel sold 848 shares at $11.78 ($9,989)
- 4 Open-market sale Chief Scientific Officer sold 1,412 shares at $11.78 ($16,633)
- 4 Open-market sale Chief Financial Officer sold 739 shares at $12.88 ($9,519)
- 4 Open-market sale General Counsel sold 699 shares at $12.88 ($9,003)
- 4 Open-market sale Chief Scientific Officer sold 1,165 shares at $12.88 ($15,006)
- 4 Open-market sale EVP and COO sold 350 shares at $12.88 ($4,508)
Page 8 of 14 · 274 filings